Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | GLA | P06280 | 2/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 1.00 |
| ▸ | HTR3A | P46098 | 1/20 | 0.65 |
| ▸ | NQO2 | P16083 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | STAT3 | P40763 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acridine SCHEMBL29352289 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTHPGDGLAACHE | |
| Acridine SCHEMBL4972293 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTHPGDGLAACHE | |
| Acridine SCHEMBL8339 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTHPGDGLAACHE | |
| Acridine SCHEMBL3045498 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTHPGDGLAACHE | |
| Acridine SCHEMBL1551975 | 0.97 | ALDH1A1 (0.94) | ALDH1A1MAPTHPGDGLAACHE | |
| Acridine SCHEMBL2394207 | 0.97 | ALDH1A1 (0.94) | ALDH1A1MAPTHPGDGLAACHE | |
| Acridine SCHEMBL641951 | 0.97 | ALDH1A1 (0.94) | ALDH1A1MAPTHPGDGLAACHE | |
| Anthracene SCHEMBL9879830 | 0.97 | MAPT (0.94) | ALDH1A1MAPTHPGDGLAACHE | |
| Acridine SCHEMBL2401648 | 0.97 | ALDH1A1 (0.94) | ALDH1A1MAPTHPGDGLAACHE | |
| Acridine SCHEMBL10801271 | 0.97 | ALDH1A1 (0.94) | ALDH1A1MAPTHPGDGLAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3059950-B1 | OPTICAL IMAGING SYSTEM FOR 3D IMAGE ACQUISITION APPARATUS AND 3D IMAGE ACQUISITION APPARATUS INCLUDING THE OPTICAL IMAGING SYSTEM | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-04-12 | — | — | EP | disclosed |
| US-10869018-B2 | Optical imaging system for 3D image acquisition apparatus and 3D image acquisition apparatus including the optical imaging system | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-12-15 | — | — | US | disclosed |
| US-10068525-B2 | Display device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-09-04 | — | — | US | disclosed |
| US-20170358764-A1 | DISPLAY DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-12-14 | — | — | US | disclosed |
| EP-3059950-A2 | OPTICAL IMAGING SYSTEM FOR 3D IMAGE ACQUISITION APPARATUS AND 3D IMAGE ACQUISITION APPARATUS INCLUDING THE OPTICAL IMAGING SYSTEM | Samsung Electronics Co., Ltd. (KR) | 2016-08-24 | — | — | EP | disclosed |
| US-20160227194-A1 | OPTICAL IMAGING SYSTEM FOR 3D IMAGE ACQUISITION APPARATUS AND 3D IMAGE ACQUISITION APPARATUS INCLUDING THE OPTICAL IMAGING SYSTEM | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-08-04 | — | — | US | disclosed |
| US-20110108845-A1 | DISPLAY DEVICE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2011-05-12 | — | — | US | disclosed |
| US-7838327-B2 | Organic light-emitting device including transparent conducting oxide layer as cathode and method of manufacturing the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-11-23 | — | — | US | disclosed |
| US-7547716-B2 | Sulfonamide derivatives | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2009-06-16 | — | — | US | disclosed |
| US-20080246050-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING TRANSPARENT CONDUCTING OXIDE LAYER AS CATHODE AND METHOD OF MANUFACTURING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2008-10-09 | — | — | US | disclosed |
| EP-1978575-A2 | Organic light-emitting device including transparent conducting oxide layer as cathode and method of manufacturing the same | Samsung SDI Co., Ltd. (KR) | 2008-10-08 | — | — | EP | disclosed |
| EP-1402890-B1 | SULFONAMIDE DERIVATIVES | INST MED MOLECULAR DESIGN INC (JP) | 2008-01-09 | — | — | EP | disclosed |
| US-20070159072-A1 | ORGANIC LIGHT EMITTING DIODE, MANUFACTURING METHOD THEREOF, AND ORGANIC LIGHT EMITTING DIODE DISPLAY PROVIDED WITH THE SAME | SAMSUNG ELECTRONICS CO., LTD (KR) | 2007-07-12 | — | — | US | disclosed |
| EP-1801900-A2 | Organic light emitting diode, manufacturing method thereof, and organic light emitting diode display provided with the same | Samsung Electronics Co., Ltd. (KR) | 2007-06-27 | — | — | EP | disclosed |
| US-20070131937-A1 | Display device and method of manufacturing thereof | SAMSUNG ELECTRONICS CO.,LTD. | 2007-06-14 | — | — | US | disclosed |
| US-20040234622-A1 | Sulfonamide derivatives | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2004-11-25 | — | — | US | disclosed |
| EP-1402890-A1 | SULFONAMIDE DERIVATIVES | Institute of Medicinal Molecular Design, Inc. (JP) | 2004-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040234622-A1 | Sulfonamide derivatives | PCNA, TOP2A, DDB1 | ALDH1A1 980/4885MAPT 4821/4885HPGD 1005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.